Listed below are the details for the data element.
FITBIR
1.0
Element Type
Common Data Element
36-item Short Form Health Survey (SF-36) version 2 - Reported Health Transition (HT) scale z-score
SF36V2RepHealthTransZScore
Short Description
z-score of subject's Reported Health Transition (HT) scale items, as part of version 2.0 of 36-item Short Form Health Survey (SF-36)
Definition
z-score of subject's Reported Health Transition (HT) scale items, as part of version 2.0 of 36-item Short Form Health Survey (SF-36)
Notes
Reported Health Transition (HT)
Creation Date
2017-01-12
Historical Notes
References
SF-36 version 2.0 was introduced to correct deficiencies identified in the original version 1. Those improvements are documented in the SF-36v2 user's manual (Ware et al., 2000; http://www.sf-36.org/announcements/SF-36_Pre-Publication_Version.pdf) and also in the following literature: https://campaign.optum.com/optum-outcomes/what-we-do/health-surveys/sf-36v2-health-survey.html. Separate permission must be obtained from OPTUM (http://www.sf-36.org) to use SF-36 v2 instrument.
Data Type
Numeric Values
Input Restrictions
Free-Form Entry
Minimum Value
0
Maximum Value
100
Population
Adult
Guidelines/Instructions
Refer to OPTUM web site for scoring and validation instructions (https://campaign.optum.com/optum-outcomes/what-we-do/health-surveys/sf-36v2-health-survey.html). Questions and values for SF-36 version 2.0 differ from version 1.0 provided by the RAND Corporation (http://www.rand.org). Separate permission must be obtained from OPTUM . (https://campaign.optum.com/optum-outcomes/what-we-do/health-surveys/sf-36v2-health-survey.html) to use SF-36 v2 instrument. Recall time should be reflected using ContextTyp and/or ContextTypOTH data elements: : standard -4 weeks, acute - during the past week. Refer to user manual for instructions on how to calculate z-scores.
Preferred Question Text
Reported Health Transition (HT) scale z-score
Category Groups and Classifications
| Disease | Domain | Sub-Domain |
|---|---|---|
| Multiple Sclerosis | Outcomes and End Points | Quality of Life |
| Myasthenia Gravis | Outcomes and End Points | Quality of Life |
| Friedreich's Ataxia | Outcomes and End Points | Quality of Life |
| Huntington's Disease | Outcomes and End Points | Quality of Life |
| Parkinson's Disease | Outcomes and End Points | Quality of Life |
| Amyotrophic Lateral Sclerosis | Outcomes and End Points | Quality of Life |
| Traumatic Brain Injury | Outcomes and End Points | Global Outcome |
| Spinal Muscular Atrophy | Outcomes and End Points | Quality of Life |
| General (For all diseases) | Outcomes and End Points | Quality of Life |
| Neuromuscular Diseases | Outcomes and End Points | Quality of Life |
| Headache | Outcomes and End Points | Quality of Life |
| Stroke | Outcomes and End Points | Quality of Life |
Classification
Traumatic Brain Injury:
Supplemental
Concussion/Mild TBI
Acute Hospitalized
Moderate/Severe TBI: Rehabilitation
Epidemiology
Headache:
Supplemental
Stroke:
Supplemental
Neuromuscular Diseases:
Supplemental
Amyotrophic Lateral Sclerosis:
Supplemental
Multiple Sclerosis:
Supplemental
Friedreich's Ataxia:
Supplemental
General (For all diseases):
Supplemental
Parkinson's Disease:
Supplemental
Myasthenia Gravis:
Supplemental
Spinal Muscular Atrophy:
Supplemental
Huntington's Disease:
Supplemental
Keywords
new
SF36v2
Labels
FITBIR_CDE
FS_CDE





